169 related articles for article (PubMed ID: 37191629)
1. Comparison of the therapeutic efficacy between systemic chemotherapy with and without radiofrequency ablation for colorectal cancer liver metastases: A propensity score matching study.
Hao W; Jun Z; Yan L; Zhong-Yi Z; Bin-Bin J; Gui-Ju L; Wei Y; Lin S; Kun Y
Br J Radiol; 2023 Aug; 96(1148):20221195. PubMed ID: 37191629
[TBL] [Abstract][Full Text] [Related]
2. Nomogram including chemotherapy response for prediction of intrahepatic progression-free survival in patients with colorectal liver metastasis through chemotherapy followed by radiofrequency ablation.
Wu H; Liu GJ; Zhang ZY; Wu W; Meng YF; Wang S; Yang W; Yan K
Int J Hyperthermia; 2021; 38(1):633-639. PubMed ID: 33882789
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant Chemotherapy Followed by Radiofrequency Ablation Prolongs Survival for Ablatable Colorectal Liver Metastasis: A Propensity Score Matching Comparative Study.
Chen Y; Xu Y; Xu L; Han F; Huang Y; Jiang H; Wu J; Zhang Y
Front Oncol; 2021; 11():758552. PubMed ID: 34745996
[TBL] [Abstract][Full Text] [Related]
4. The prognosis of radiofrequency ablation versus hepatic resection for patients with colorectal liver metastases: A systematic review and meta-analysis based on 22 studies.
Yang G; Wang G; Sun J; Xiong Y; Li W; Tang T; Li J
Int J Surg; 2021 Mar; 87():105896. PubMed ID: 33588125
[TBL] [Abstract][Full Text] [Related]
5. Radiofrequency ablation as a treatment tool for liver metastases of colorectal origin.
Hompes D; Prevoo W; Ruers T
Cancer Imaging; 2011 Mar; 11(1):23-30. PubMed ID: 21435988
[TBL] [Abstract][Full Text] [Related]
6. Potential for cure and predictors of long-term survival after radiofrequency ablation for colorectal liver metastases: A 20-years single-center experience.
Weilert H; Sadeghi D; Lipp M; Oldhafer KJ; Donati M; Stang A
Eur J Surg Oncol; 2022 Dec; 48(12):2487-2494. PubMed ID: 35718675
[TBL] [Abstract][Full Text] [Related]
7. Propensity score matching demonstrates similar results for radiofrequency ablation compared to surgical resection in colorectal liver metastases.
van de Geest TW; van Amerongen MJ; Nierop PMH; Höppener DJ; Grünhagen DJ; Moelker A; Fütterer JJ; Verhoef C; de Wilt JHW
Eur J Surg Oncol; 2022 Jun; 48(6):1368-1374. PubMed ID: 35078702
[TBL] [Abstract][Full Text] [Related]
8. Hepatic resection combined with radiofrequency ablation for initially unresectable colorectal liver metastases after effective chemotherapy is a safe procedure with a low incidence of local recurrence.
Mima K; Beppu T; Chikamoto A; Miyamoto Y; Nakagawa S; Kuroki H; Okabe H; Hayashi H; Sakamoto Y; Watanabe M; Kikuchi K; Baba H
Int J Clin Oncol; 2013 Oct; 18(5):847-55. PubMed ID: 22940848
[TBL] [Abstract][Full Text] [Related]
9. Radiofrequency ablation versus resection for technically resectable colorectal liver metastasis: a propensity score analysis.
Wang LJ; Zhang ZY; Yan XL; Yang W; Yan K; Xing BC
World J Surg Oncol; 2018 Oct; 16(1):207. PubMed ID: 30322402
[TBL] [Abstract][Full Text] [Related]
10. Short- and long-term outcomes of hepatectomy combined with intraoperative radiofrequency ablation for patients with multiple primarily unresectable colorectal liver metastases: a propensity matching analysis.
Liu M; Wang K; Wang Y; Bao Q; Wang H; Jin K; Liu W; Xing B
HPB (Oxford); 2021 Oct; 23(10):1586-1594. PubMed ID: 33934959
[TBL] [Abstract][Full Text] [Related]
11. Radiofrequency versus microwave ablation for intraoperative treatment of colorectal liver metastases.
Krul MF; Gerritsen SL; Vissers FL; Klompenhouwer EG; Ruers TJ; Kuhlmann KF; Kok NF
Eur J Surg Oncol; 2022 Apr; 48(4):834-840. PubMed ID: 34686404
[TBL] [Abstract][Full Text] [Related]
12. Hepatectomy vs radiofrequency ablation for colorectal liver metastasis: a propensity score analysis.
Lee H; Heo JS; Cho YB; Yun SH; Kim HC; Lee WY; Choi SH; Choi DW
World J Gastroenterol; 2015 Mar; 21(11):3300-7. PubMed ID: 25805937
[TBL] [Abstract][Full Text] [Related]
13. Does the Site of the Primary Affect Outcomes When Ablating Colorectal Liver Metastases with Radiofrequency Ablation?
Gu Y; Huang Z; Gu H; Gao F; Zhang T; Huang S; Huang J
Cardiovasc Intervent Radiol; 2018 Jun; 41(6):912-919. PubMed ID: 29582125
[TBL] [Abstract][Full Text] [Related]
14. Combination therapy with PD-1 blockade and radiofrequency ablation for recurrent hepatocellular carcinoma: a propensity score matching analysis.
Wang X; Liu G; Chen S; Bi H; Xia F; Feng K; Ma K; Ni B
Int J Hyperthermia; 2021 Oct; 38(1):1519-1528. PubMed ID: 34702122
[TBL] [Abstract][Full Text] [Related]
15. Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: Propensity score analyses of long-term outcomes.
Lee S; Kang TW; Cha DI; Song KD; Lee MW; Rhim H; Lim HK; Sinn DH; Kim JM; Kim K
J Hepatol; 2018 Jul; 69(1):70-78. PubMed ID: 29524532
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes of surgical resection versus radiofrequency ablation in very-early-stage hepatocellular carcinoma: a propensity score matching analysis.
Li YC; Chen PH; Yeh JH; Hsiao P; Lo GH; Tan T; Cheng PN; Lin HY; Chen YS; Hsieh KC; Hsieh PM; Lin CW
BMC Gastroenterol; 2021 Nov; 21(1):418. PubMed ID: 34749663
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcomes of radiofrequency ablation combined with hepatectomy compared with hepatectomy alone for colorectal liver metastases.
Imai K; Allard MA; Castro Benitez C; Vibert E; Sa Cunha A; Cherqui D; Castaing D; Baba H; Adam R
Br J Surg; 2017 Apr; 104(5):570-579. PubMed ID: 28112813
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of microwave ablation versus radiofrequency ablation in the treatment of colorectal liver metastases: A systematic review and meta-analysis.
Tang Y; Zhong H; Wang Y; Wu J; Zheng J
Clin Res Hepatol Gastroenterol; 2023 Aug; 47(7):102182. PubMed ID: 37479137
[TBL] [Abstract][Full Text] [Related]
19. Recurrence and survival following microwave, radiofrequency ablation, and hepatic resection of colorectal liver metastases: A systematic review and network meta-analysis.
Gavriilidis P; Roberts KJ; de'Angelis N; Aldrighetti L; Sutcliffe RP
Hepatobiliary Pancreat Dis Int; 2021 Aug; 20(4):307-314. PubMed ID: 34127382
[TBL] [Abstract][Full Text] [Related]
20. Microwave ablation versus radiofrequency ablation for perivascular hepatocellular carcinoma: a propensity score analysis.
Feng Y; Wang L; Lv H; Shi T; Xu C; Zheng H; Qi J; Zhao X; Li J; Gao Y; Qin C; Zhu Q
HPB (Oxford); 2021 Apr; 23(4):512-519. PubMed ID: 32839089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]